SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- The painful cry of Checo Pérez when he felt the shock of Carlos Sainz for not braking May 28, 2022
- UK struggles with bollard shortage | FormulaPassion.it Jul 27, 2021
- Preventive Early Warning is declared for the Los Lagos region due to rain and storm forecast Dec 7, 2022
- OL, Garcia does not rule out anything for his future Apr 19, 2021
- Drought in the Alpes-Maritimes: Water restriction measures extended until December 15 Nov 18, 2022
- CFPB accuses LendUp of again deceiving borrowers Sep 8, 2021
- Britney Spears recovers her dogs that would have been kidnapped by her housekeeper Aug 22, 2021